Last edition
News about "Swiss Agency for Therapeutic Products"
Abbisko Therapeutics Secures US FDA Approval for Pimjetmi to Treat TGCT
Abbisko Therapeutics’ Pimjetmi receives US FDA approval as a systemic treatment for adults with symptomatic tenosynovial giant cell tumour.
Swiss Agency For Therapeutic Products | 12/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members